Login / Signup
BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis.
Faezeh Zakerinasab
Qumars Behfar
Reza Parsaee
Reza Hossein Zadeh
Elaheh Foroughi
Amirhesam Amirbeik
Ghazalehsadat Ahmadi
Published in:
BMC genomic data (2024)
= 94.82%) CONCLUSIONS: Our meta-analysis investigates a 2% prevalence of BRCA1/2 mutation in patients with uterine cancer. Patients with BRCA1/2 mutations might be more conscious of uterine malignancies.
Keyphrases
</>
papillary thyroid
systematic review
squamous cell
risk factors
lymph node metastasis
randomized controlled trial
childhood cancer
young adults